BI Asset Management Fondsmaeglerselskab A S Sells 2,222 Shares of Axon Enterprise, Inc $AXON

BI Asset Management Fondsmaeglerselskab A S lessened its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 41.6% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 3,123 shares of the biotechnology company’s stock after selling 2,222 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Axon Enterprise were worth $1,326,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Evergreen Capital Management LLC increased its holdings in Axon Enterprise by 3.8% in the 2nd quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock valued at $342,000 after acquiring an additional 15 shares during the last quarter. Quadrant Capital Group LLC lifted its stake in Axon Enterprise by 0.5% in the 3rd quarter. Quadrant Capital Group LLC now owns 3,968 shares of the biotechnology company’s stock worth $2,848,000 after purchasing an additional 19 shares in the last quarter. CWA Asset Management Group LLC boosted its holdings in shares of Axon Enterprise by 5.2% during the 4th quarter. CWA Asset Management Group LLC now owns 387 shares of the biotechnology company’s stock valued at $220,000 after purchasing an additional 19 shares during the last quarter. Synergy Financial Group LTD boosted its holdings in shares of Axon Enterprise by 1.4% during the 3rd quarter. Synergy Financial Group LTD now owns 1,388 shares of the biotechnology company’s stock valued at $996,000 after purchasing an additional 19 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its position in shares of Axon Enterprise by 1.2% during the second quarter. Tower Research Capital LLC TRC now owns 1,631 shares of the biotechnology company’s stock valued at $1,350,000 after purchasing an additional 19 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In related news, President Joshua Isner sold 13,000 shares of Axon Enterprise stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the completion of the sale, the president owned 169,125 shares in the company, valued at $82,609,106.25. This trade represents a 7.14% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Isaiah Fields sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $400.00, for a total transaction of $800,000.00. Following the transaction, the insider directly owned 52,813 shares in the company, valued at approximately $21,125,200. This trade represents a 3.65% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 38,989 shares of company stock valued at $19,090,083. Company insiders own 4.20% of the company’s stock.

Analyst Ratings Changes

AXON has been the topic of several research reports. JPMorgan Chase & Co. lifted their target price on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Wall Street Zen upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Citigroup reissued a “buy” rating on shares of Axon Enterprise in a report on Wednesday, February 25th. UBS Group reduced their price target on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research report on Thursday, May 7th. Finally, Zacks Research raised shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 19th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $712.75.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon’s president said the company’s counter-drone platform, Dedrone, has already generated more bookings than its acquisition price, reinforcing the view that the deal is paying off and that Axon’s expansion into drone defense is gaining traction. Axon (AXON) Stock Trades Up, Here Is Why
• Positive Sentiment: Investors are also reacting to Axon’s growing AI story, with commentary highlighting that the company can offer AI upside without the heavy infrastructure spending required by many large AI names. Axon Offers AI Upside Without the Infrastructure Gamble
• Positive Sentiment: Recent articles continue to emphasize Axon’s strong Q1 results, raised full-year revenue outlook, and expanding AI-powered public safety platform, which supports the bullish case for future growth and recurring software revenue. Does Axon’s Upgraded Outlook and AI Push Reshape The Bull Case For Axon Enterprise (AXON)?
• Neutral Sentiment: Axon was also featured in industry outlook pieces alongside other aerospace-defense names, keeping the stock in view but without a new direct catalyst. Zacks Industry Outlook HEICO, Axon and AAR
• Negative Sentiment: A separate article raised questions about Axon’s Scottsdale development plans and political ties, which could create some reputational or governance overhang for investors. Axon (AXON) Faces Questions Over Scottsdale Election Ties And Development Project

Axon Enterprise Trading Up 5.5%

AXON opened at $456.73 on Thursday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. The stock’s 50 day moving average price is $418.11 and its 200-day moving average price is $482.95. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91. The stock has a market cap of $36.81 billion, a price-to-earnings ratio of 183.43, a P/E/G ratio of 7.87 and a beta of 1.45.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.90 million. During the same period last year, the company earned $1.47 EPS. Axon Enterprise’s quarterly revenue was up 33.7% compared to the same quarter last year. On average, equities analysts forecast that Axon Enterprise, Inc will post 1.82 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.